Effect of SBE7-β-cyclodextrin complexation on carbamazepine release from sustained release beads

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 60, Issue 1, 2005, Pages 73-80

  Smith, J S ^a   MacRae, R J ^a   Snowden, M J ^b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Beads; Carbamazepine; Cyclodextrin; Hydroxypropyl methylcellulose; Sustained release

Indexed keywords

CARBAMAZEPINE; CYCLODEXTRIN DERIVATIVE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; METHYLCELLULOSE; POVIDONE; SULFOBUTYL ETHER 7 BETA CYCLODEXTRIN; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG POTENTIATION; DRUG SOLUBILITY; INTERMETHOD COMPARISON; ROOM TEMPERATURE; SUSTAINED DRUG RELEASE;

EID: 17444415305     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.12.001     Document Type: Article

References (25)

1. A.G. Ozturk, S.S. Ozturk, B.O. Palsson, T.A. Wheatley, and J.B. Dressman Mechanism of release from pellets coated with an ethylcellulose-based film J. Control. Rel. 14 1990 203 213
2. G.V. Savage, and C.T. Rhodes The sustained release coating of solid dosage forms: a historical review Drug Dev. Ind. Pharm. 21 1 1995 93 118
3. M.R. Harris, and I. Ghebre-Sellassie Aqueous polymeric coating for modified release oral dosage forms J.W. McGinity Drugs and Pharmaceutical Sciences: Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms vol. 79 1997 Marcel Dekker New York 81 100
4. K.O.R. Lehmann Chemistry and application properties of polymethacrylate coating systems J.W. McGinity Drugs and Pharmaceutical Sciences: Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms vol. 79 1997 Marcel Dekker New York 101 176
5. S.C. Porter Controlled-release film coatings based on ethylcellulose Drug Dev. Ind. Pharm. 15 10 1989 1495 1521
6. V.J. Stella, R.T. Rajewski, Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and pharmaceutical use thereof, US Patent 5,134,127, 18 July, 1992.
7. T. Loftsson, and M.E. Brewster Cyclodextrins as pharmaceutical excipients Pharm. Tech. Eur. May May 1997 26 34
8. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins 1. Drug solubilisation and stabilization J. Pharm. Sci. 85 10 1996 1017 1025
9. C.J. Betlach, M.A. Gonzalez, B.C. McKiernan, C. Neff-Davis, and N. Bodor Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex J. Pharm. Sci. 82 10 1993 1058 1060
10. K. Uekama, and F. Hirayama Improvement of Drug Properties by Cyclodextrins Practice of Medicinal Chemistry 1996 Academic Press New York pp. 793-825
11. K. Okimoto, R.A. Rajewski, K. Uekama, J.A. Jona, and V.J. Stella The interaction of charged and uncharged neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins Pharm. Res. 13 2 1996 256 264
12. T. Loftsson, and H. Frioriksdóttir The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin Int. J. Pharm. 163 1998 115 121
13. T. Loftsson, E. Stefánsson, H. Frioriksdóttir, and J.K. Kristinsson Novel CD based drug delivery system J. Szejtli Proceedings of the Eighth International Symposium on Cyclodextrins 1996 Kluwer Dordrecht 407 412
14. T. Higuchi, and R. Kuramoto Study of possible complex formation between macromolecules and certain pharmaceuticals J. Am. Pharm. Assoc. Sci. Ed. 43 1954 393 401
15. T. Loftsson, H. Frioriksdóttir, and T.K. Guomunsdóttir The effect of water-soluble polymers on the aqueous solubility of drugs Int. J. Pharm. 127 2 1996 293 296
16. I. Katzhendler, R. Azoury, and M. Friedman Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose J. Control. Rel. 54 1998 69 85
17. M.A. Al-Meshal, G.M. El-Mahrook, A.A. Al-Angary, and M.W. Gouda Interaction of carbamazepine with cyclodextrins Pharm. Ind. 55 12 1993 1129 1132
18. H. Ueda, D. Ou, T. Endo, H. Nagase, K. Tomono, and T. Nagai Evaluation of a sulfobutyl ether β-cyclodextrin as a solubilising/stabilizing agent for several drugs Drug. Dev. Ind. Pharm. 24 9 1998 863 867
19. T. Hoshino, K. Uekama, and J. Pitha Increase in temperature enhances solubility of drugs in aqueous solutions of hydroxypropylcyclodextrins Int. J. Pharm. 98 1993 239 242
20. S.A. El-Nahhas Physico-chemical characteristics of carbamazepine-β- cyclodextrin inclusion compounds and carbamazepine-PEG solid dispersions Pharmazia 51 12 1996 960 963
21. T. Higuchi, and K.A. Connors Phase-Solubility Techniques C.N. Reilley Advances in Analytical Chemistry and Instrumentation vol. 4 1965 Wiley-Interscience London 117 212
22. 7m-β-CD on methylprednisolone transport across ethylcellulose microporous membranes J.J. Torres Lababdeira J.L. Vila Jato Proceedings of the Ninth International Symposium on Cyclodextrins, Santiago de Compostela, Spain 1999 Kluwer Dordrecht 445 448
23. 7m-β-cyclodextrin as both a solubilizing and an osmotic pump agent J. Control. Rel. 58 1999 29 38
24. 7m-β-CD Pharm. Res. 15 10 1998 1562 1568
25. F. Sadeghi, J.L. Ford, M.H. Rubinstein, and A.R. Rajabi-Siahboomi Comparative study of drug release from pellets coated with HPMC or surelease Drug Dev. Ind. Pharm. 26 6 2000 651 660